CA2389537A1 - Melange de produits tires de l'huile de graine et du jus de grenade - Google Patents

Melange de produits tires de l'huile de graine et du jus de grenade Download PDF

Info

Publication number
CA2389537A1
CA2389537A1 CA002389537A CA2389537A CA2389537A1 CA 2389537 A1 CA2389537 A1 CA 2389537A1 CA 002389537 A CA002389537 A CA 002389537A CA 2389537 A CA2389537 A CA 2389537A CA 2389537 A1 CA2389537 A1 CA 2389537A1
Authority
CA
Canada
Prior art keywords
pomegranate
juice
seed oil
composition
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002389537A
Other languages
English (en)
Inventor
Ephraim Philip Lansky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rimonest Ltd
Original Assignee
Rimonest Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rimonest Ltd filed Critical Rimonest Ltd
Publication of CA2389537A1 publication Critical patent/CA2389537A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CA002389537A 1999-11-29 2000-11-29 Melange de produits tires de l'huile de graine et du jus de grenade Abandoned CA2389537A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16769499P 1999-11-29 1999-11-29
US60/167,694 1999-11-29
PCT/IL2000/000800 WO2001037848A1 (fr) 1999-11-29 2000-11-29 Melange de produits tires de l'huile de graine et du jus de grenade

Publications (1)

Publication Number Publication Date
CA2389537A1 true CA2389537A1 (fr) 2001-05-31

Family

ID=22608424

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002389537A Abandoned CA2389537A1 (fr) 1999-11-29 2000-11-29 Melange de produits tires de l'huile de graine et du jus de grenade

Country Status (7)

Country Link
EP (1) EP1233773A4 (fr)
JP (1) JP2003514865A (fr)
AU (1) AU774619B2 (fr)
CA (1) CA2389537A1 (fr)
IL (1) IL149521A0 (fr)
WO (1) WO2001037848A1 (fr)
ZA (1) ZA200203898B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7611738B2 (en) 2005-05-24 2009-11-03 Pom Wonderful, Llc Processes for extracting phytochemicals from pomegranate solids and compositions and methods of use thereof
US6641850B1 (en) * 1999-04-19 2003-11-04 Stewart And Lynda Resnick Revocable Trust Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans
US7727563B2 (en) 1999-04-19 2010-06-01 Pom Wonderful, Llc Methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans
US8372454B2 (en) 1999-04-19 2013-02-12 Pom Wonderful Llc Methods of making pomegranate compounds for the treatment of erectile dysfunction
WO2004056444A1 (fr) * 2002-12-19 2004-07-08 Council Of Scientific And Industrial Research Procede d'extraction de principes antioxydants de dechets de grenade
US20080044504A1 (en) * 2004-07-05 2008-02-21 Marukin Bio, Inc. Pomegranate Juice, Pomegranate Juice Powder and Process for Producing the Powder
US8609152B2 (en) 2005-05-24 2013-12-17 Mohammad Madjid Compositions and methods for extracting and using phytochemicals for the treatment of influenza
WO2007106909A2 (fr) 2006-03-15 2007-09-20 Pom Wonderful, Llc Procédé d'utilisation d'extraits de grenade pour accroître le temps de doublement de l'antigène spécifique de la prostate
US7875741B2 (en) 2006-06-27 2011-01-25 Jawaharlal Nehru Centre For Advanced Scientific Research Site-specific inhibitors of histone methyltransferase [HMTase] and process of preparation thereof
JP2011502518A (ja) * 2007-11-07 2011-01-27 ケリー グループ サーヴィシーズ インターナショナル、リミテッド 香味料
JP5654214B2 (ja) * 2008-06-04 2015-01-14 丸善製薬株式会社 抑毛剤及び抑毛用皮膚化粧料
EP2132994B1 (fr) * 2008-06-11 2010-05-26 Ludwig Manfred Jacob Fermentation de solutions contenant du jus de grenade à l'aide de saccharomyces boulardii et de lactobaciles, produits de fermentation ainsi obtenus et leur utilisation
JP5770462B2 (ja) * 2010-07-22 2015-08-26 株式会社クワン 種子入りザクロジュースの製造方法、その製造方法から成る種子入りザクロジュース及び前記種子入りザクロジュースを使用して成るザクロ果汁入りゼリー
EP2844265A4 (fr) 2012-04-25 2016-01-06 Hadasit Med Res Service Huile de grenade pour prévenir et traiter des maladies neurodégénératives
IT201600093758A1 (it) * 2016-09-19 2018-03-19 Codex V Srl Insaponificabili di lipidi naturali per l’uso nel trattamento di patologie tumorali
CN109042854B (zh) * 2018-10-23 2021-12-24 云南省农业科学院农产品加工研究所 一种石榴籽的保鲜方法
JP7237998B2 (ja) * 2021-01-08 2023-03-13 小林製薬株式会社 ホスホジエステラーゼ５活性阻害用組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1013027B (it) * 1972-03-31 1977-03-30 Trebjesa Ind Piava Ulja I Soko Procedimento per la produzione di succo di melagrana
DE4312109A1 (de) * 1992-11-14 1994-10-20 Khalil Ahmad Haarwuchssystem und Haarwasser gegen Haarausfall
RU2070051C1 (ru) * 1992-10-15 1996-12-10 Нижегородский научно-исследовательский институт детской гастроэнтерологии Средство гриколо для лечения диареи
WO1996000510A1 (fr) * 1994-06-28 1996-01-11 The Procter & Gamble Company Sirops stables de distributeur de boisson contenant une phase huileuse et procede de stabilisation de la phase huileuse
US5891440A (en) * 1996-12-31 1999-04-06 Lansky; Ephraim Philip Phytoestrogen supplement prepared from pomegranate seeds and a herbal mixture or coconut milk

Also Published As

Publication number Publication date
AU1728201A (en) 2001-06-04
ZA200203898B (en) 2003-06-10
EP1233773A1 (fr) 2002-08-28
JP2003514865A (ja) 2003-04-22
AU774619B2 (en) 2004-07-01
EP1233773A4 (fr) 2004-10-06
WO2001037848A1 (fr) 2001-05-31
IL149521A0 (en) 2002-11-10

Similar Documents

Publication Publication Date Title
US20020012710A1 (en) Pomegranate products useful in improving health and methods of use thereof
AU774619B2 (en) Mixture of pomegranate seed oil and juice products
Bolton et al. The multiple biological targets of hops and bioactive compounds
Lansky et al. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer
Dehpour et al. Antioxidant activity of the methanol extract of Ferula assafoetida and its essential oil composition
Andrikopoulos et al. Biological activity of some naturally occurring resins, gums and pigments against in vitro LDL oxidation
Kroyer Red clover extract as antioxidant active and functional food ingredient
Nessa et al. Free radical-scavenging activity of organic extracts and of pure flavonoids of Blumea balsamifera DC leaves
JP4852685B2 (ja) ガンの予防におけるヒドロキシマタイレシノール
Keta et al. Pomegranate (Punica granatum L.) Peel Extract: potential cytotoxic agent against different cancer cell lines
EP2214688B1 (fr) Contrôle et traitement de l'hyperplasie prostatique bénigne
KR101831981B1 (ko) 상동나무 추출물 또는 이의 분획물을 유효성분으로 함유하는 암의 예방, 개선 또는 치료용 조성물
Su et al. Evaluating skin cancer chemopreventive potential of water extract of Syzygium samarangense leaves through activation of the Nrf2-mediated cellular defense system
Khunchalee et al. The Study of Free radical Scavenging, Total Phenolic Contents, and Tyrosinase Inhibition Activity of Crude Extract from Moringa oleifera Lam.
Shi et al. Phenolic Composition, Antioxidant, and α-Glucosidase Inhibitory Activities of Extracts from Polygonatum sibiricum
KR101069906B1 (ko) 비짜루국화 추출물을 함유하는 피부 상태개선용 조성물
KR20070078658A (ko) 누리장나무 잎으로부터 악테오사이드를 추출하는 방법 및이를 함유하는 항산화 및 항염증 약학조성물
WO2009012910A1 (fr) Dérivés de stilbène biologiquement actifs et leurs compositions
Sajad et al. Occurrence and bioactivity of phytochemicals and their role in human health
Guo et al. Anticancer and Antioxidant Activities of Aqueous and Ethanolic Bark Extracts of Acer Tegmentosum Maxim (Aceaceae) on Tumor Cell Lines.
Al-Wajih et al. Literature review of Aloe vera cytotoxicity
Basdogan et al. The effect of press temperature on the total tocopherols, sterol, fatty acid, phenolic profile, in-vitro cytotoxicity assay, and anti-inflammatory activity
WO2009011811A1 (fr) Compositions dérivées de garcinia en tant qu'inhibiteurs d'aromatase pour la chimioprévention et la chimiothérapie du cancer du sein
KR20170045770A (ko) 오스만투스 마츠무라누스 추출물을 포함하는 항산화 또는 항염증 조성물
JP2010180153A (ja) エストロジェン代替組成物

Legal Events

Date Code Title Description
FZDE Discontinued